{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:29:50Z","timestamp":1791602990966,"version":"4.3.4"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Previous studies suggest that children exposed to COVID-19 during pregnancy may have an increased risk of neurodevelopmental disorders. However, these studies had limited follow-up periods and primarily evaluated broad neurodevelopmental concerns.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine whether exposure to maternal COVID-19 during pregnancy is associated with an increased risk of neurodevelopmental or neurological disorders among offspring.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study was conducted between November 2025 and February 2026. The sample included all children born in Norway between March 1, 2020, and December 31, 2023, with 22 completed gestational weeks and a birth weight greater than 500 g. Data were obtained from national registries, including maternal background characteristics from Statistics Norway, birth characteristics from the Medical Birth Registry of Norway, prenatal exposure to COVID-19 from the Norwegian Surveillance System for Communicable Diseases, and neurodevelopmental and neurological disorders from the Norwegian Patient Registry.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Maternal COVID-19 during pregnancy, which was defined as a positive PCR result for SARS-CoV-2 infection between conception (date of birth minus the gestational duration in days) and the date of delivery.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The 8 outcomes of interest were any neurodevelopmental disorders, pervasive neurodevelopmental disorders (autism), developmental speech or language disorders, developmental motor disorders, intellectual disorders, any neurological disorders, epilepsy, and sensory impairments. Diagnoses of neurodevelopmental disorders, neurological disorders, and sensory impairments were registered in the national patient registries. Risks were evaluated using Cox proportional hazards regression.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among the 204\u202f663 children (104\u202f728 males [51.2%]) included in this study, 16\u202f325 (8.0%) were exposed to maternal COVID-19 during pregnancy. Exposed children did not have increased risk of any neurodevelopmental disorders (adjusted hazard ratio [AHR], 0.97; 95% CI, 0.88-1.08), pervasive neurodevelopment disorders (AHR, 0.88; 95% CI, 0.67-1.15), developmental speech or language disorders (AHR 1.13; 95% CI, 0.80-1.59), developmental motor disorders (AHR, 0.83; 95% CI, 0.44-1.56), intellectual disorders (AHR, 1.19; 95% CI, 0.65-2.19), any neurological disorders (AHR, 0.97; 95% CI, 0.88-1.07), epilepsy (AHR, 1.14; 95% CI, 0.87-1.48), or sensory impairments (AHR, 1.09; 95% CI, 0.92-1.30). These findings were mostly robust across sensitivity analyses and did not vary according to trimester of exposure or the dominant circulating SARS-CoV-2 variant. The exception was an increased risk of speech or language disorders among exposed children, excluding children born after March 1, 2022 (AHR, 2.22; 95% CI, 1.44-3.41); this sensitivity analysis was performed to limit misclassification due to reduced availability of SARS-CoV-2 testing.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this population-based cohort study, children exposed to maternal COVID-19 prenatally did not show an increased risk of neurodevelopmental disorders, aside from an increased risk of speech or language disorders among those exposed in the early phase of the pandemic. These findings should be replicated in other populations and settings.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.31847","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:03:54Z","timestamp":1788451434000},"page":"e2631847","source":"Crossref","is-referenced-by-count":1,"title":["Prenatal COVID-19 Exposure and Neurodevelopmental and Neurological Disorders in Children"],"prefix":"10.1001","volume":"9","author":[{"given":"Maria C.","family":"Magnus","sequence":"first","affiliation":[{"name":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena N.","family":"Eide","sequence":"additional","affiliation":[{"name":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Burgner","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Royal Children\u2019s Hospital, Parkville, Victoria, Australia"},{"name":"Faculty of Health, Deakin University, Burwood, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Stephansson","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Women\u2019s Health, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Eldevik H\u00e5berg","sequence":"additional","affiliation":[{"name":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"1","key":"zoi260878r1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/imr.13125","article-title":"At the crux of maternal immune activation: viruses, microglia, microbes, and IL-17A.","volume":"311","author":"Otero","year":"2022","journal-title":"Immunol Rev"},{"key":"zoi260878r2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpsychires.2018.02.007","article-title":"Maternal immune activation induced by lipopolysaccharide triggers immune response in pregnant mother and fetus, and induces behavioral impairment in adult rats.","volume":"100","author":"Sim\u00f5es","year":"2018","journal-title":"J Psychiatr Res"},{"key":"zoi260878r3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3389\/fimmu.2020.01145","article-title":"Maternal immune activation alters fetal brain development and enhances proliferation of neural precursor cells in rats.","volume":"11","author":"Baines","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"zoi260878r4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.biopsych.2016.10.020","article-title":"Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates.","volume":"81","author":"Careaga","year":"2017","journal-title":"Biol Psychiatry"},{"issue":"5","key":"zoi260878r5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.medj.2021.04.016","article-title":"Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface.","volume":"2","author":"Lu-Culligan","year":"2021","journal-title":"Med"},{"issue":"617","key":"zoi260878r6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi7428","article-title":"Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses.","volume":"13","author":"Bordt","year":"2021","journal-title":"Sci Transl Med"},{"issue":"7","key":"zoi260878r7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41556-023-01169-x","article-title":"Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal-fetal interface following SARS-CoV-2 infection.","volume":"25","author":"Gao","year":"2023","journal-title":"Nat Cell Biol"},{"issue":"1","key":"zoi260878r8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41467-021-27745-z","article-title":"Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2.","volume":"13","author":"Garcia-Flores","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"zoi260878r9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s43856-023-00268-y","article-title":"Pregnancy-specific responses to COVID-19 revealed by high-throughput proteomics of human plasma.","volume":"3","author":"Gomez-Lopez","year":"2023","journal-title":"Commun Med (Lond)"},{"issue":"4","key":"zoi260878r10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molmed.2022.02.004","article-title":"COVID-19 in pregnancy: implications for fetal brain development.","volume":"28","author":"Shook","year":"2022","journal-title":"Trends Mol Med"},{"issue":"1","key":"zoi260878r11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2023-000314","article-title":"Infection with SARS-CoV-2 during pregnancy and risk of stillbirth: a Scandinavian registry study.","volume":"1","author":"Magnus","year":"2023","journal-title":"BMJ Public Health"},{"issue":"1","key":"zoi260878r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-009495","article-title":"Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis.","volume":"8","author":"Smith","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"1","key":"zoi260878r13","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1186\/s12884-025-08090-1","article-title":"Neonatal outcomes among pregnant women with COVID-19: a systematic scoping review and meta-analysis.","volume":"25","author":"Li","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"zoi260878r14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/aogs.14764","article-title":"Outcomes of SARS-CoV-2 infection in early pregnancy-a systematic review and meta-analysis.","volume":"103","author":"Rodriguez-Wallberg","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"zoi260878r15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.cmi.2024.10.019","article-title":"Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA-COVID-19 vaccine compared with unexposed infants: a COVI-PREG prospective cohort study.","volume":"31","author":"Favre","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"zoi260878r16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S2352-4642(25)00008-2","article-title":"Early childhood developmental concerns following SARS-CoV-2 infection and COVID-19 vaccination during pregnancy: a Scottish population-level retrospective cohort study.","volume":"9","author":"Hardie","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"issue":"10","key":"zoi260878r17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.39792","article-title":"In utero exposure to maternal COVID-19 and offspring neurodevelopment through age 24 months.","volume":"7","author":"Jaswa","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260878r18","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1038\/s41598-024-61918-2","article-title":"Neurodevelopmental delay in children exposed to maternal SARS-CoV-2 in-utero.","volume":"14","author":"Fajardo-Martinez","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"zoi260878r19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41372-023-01642-3","article-title":"Developmental screening of full-term infants at 16 to 18 months of age after in-utero exposure to maternal SARS-CoV-2 infection.","volume":"43","author":"Shah","year":"2023","journal-title":"J Perinatol"},{"key":"zoi260878r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2026.114997","article-title":"Intrauterine SARS-CoV-2 exposure and infant neurodevelopment through 18 months of age: findings from the Researching COVID to Enhance Recovery (RECOVER) Pregnancy Study.","volume":"292","author":"Flaherman","year":"2026","journal-title":"J Pediatr"},{"issue":"5","key":"zoi260878r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2026.106749","article-title":"Maternal SARS-CoV-2 infection and early child growth and development: a nationwide cohort study.","volume":"92","author":"Beharier","year":"2026","journal-title":"J Infect"},{"issue":"1","key":"zoi260878r22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/AOG.0000000000006112","article-title":"Neurodevelopmental outcomes of 3-year-old children exposed to maternal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in utero.","volume":"147","author":"Shook","year":"2026","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi260878r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.4415","article-title":"Sex-specific neurodevelopmental outcomes among offspring of mothers with SARS-CoV-2 infection during pregnancy.","volume":"6","author":"Edlow","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi260878r24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.15787","article-title":"Neurodevelopmental outcomes at 1 year in infants of mothers who tested positive for SARS-CoV-2 during pregnancy.","volume":"5","author":"Edlow","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260878r25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41398-026-03818-9","article-title":"SARS-CoV-2 infection during pregnancy and neurodevelopmental outcomes in early childhood.","volume":"16","author":"Croen","year":"2026","journal-title":"Transl Psychiatry"},{"key":"zoi260878r26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.860110","article-title":"Prenatal environment and neurodevelopmental disorders.","volume":"13","author":"Doi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"zoi260878r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114326","article-title":"Hofbauer cells and fetal brain microglia share transcriptional profiles and responses to maternal diet-induced obesity.","volume":"43","author":"Batorsky","year":"2024","journal-title":"Cell Rep"},{"issue":"1","key":"zoi260878r29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12974-024-03157-w","article-title":"Maternal SARS-CoV-2 impacts fetal placental macrophage programs and placenta-derived microglial models of neurodevelopment.","volume":"21","author":"Shook","year":"2024","journal-title":"J Neuroinflammation"},{"issue":"3","key":"zoi260878r30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awac372","article-title":"Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection.","volume":"146","author":"Massimo","year":"2023","journal-title":"Brain"},{"issue":"1","key":"zoi260878r31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41467-025-56560-z","article-title":"Unraveling microglial spatial organization in the developing human brain with DeepCellMap, a deep learning approach coupled with spatial statistics.","volume":"16","author":"Perochon","year":"2025","journal-title":"Nat Commun"},{"issue":"10","key":"zoi260878r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.38941","article-title":"COVID-19 pandemic and infant neurodevelopmental impairment: a systematic review and meta-analysis.","volume":"5","author":"Hessami","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi260878r33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3892\/etm.2026.13132","article-title":"Disrupted beginnings: neurodevelopmental outcomes of COVID-19 lockdowns in early childhood (review).","volume":"31","author":"Giannopoulou","year":"2026","journal-title":"Exp Ther Med"},{"issue":"2","key":"zoi260878r34","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1097\/DBP.0000000000001352","article-title":"Effects of the COVID-19 pandemic on early child development: a systematic review & meta-analysis.","volume":"46","author":"O\u2019Connor","year":"2025","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"zoi260878r35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","article-title":"Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies.","volume":"27","author":"Solmi","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"4","key":"zoi260878r36","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jaac.2025.09.031","article-title":"Systematic review and meta-analysis: acetaminophen use during pregnancy and the risk of neurodevelopmental disorders in childhood.","volume":"65","author":"B\u00e9rard","year":"2026","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"zoi260878r27","unstructured":"Variants of the SARS-CoV-2 virus. FHI Statistikk. Accessed January 26, 2026. https:\/\/statistikk.fhi.no\/ngs\/-szwfiFNMpkEPblhduqLlbpagWcYEPgiImStYTZA1_s"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2853621\/magnus_2026_oi_260878_1791293632.34344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:00:18Z","timestamp":1791558018000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2853621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.31847","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}